Meta Biomed Co. Ltd (059210) — Cash Flow Quality Index
Meta Biomed Co. Ltd (059210) has a Cash Flow Quality Index of 0.24x as of September 2025. Operating cash flow of ₩1.05 Billion is below net income of ₩4.46 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Meta Biomed Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Meta Biomed Co. Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Meta Biomed Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Meta Biomed Co. Ltd generate cash.
Annual Cash Flow Quality Index for Meta Biomed Co. Ltd (2011–2024)
Year-by-year earnings quality comparison for Meta Biomed Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.01x | ₩22.63 Billion | ₩22.32 Billion | ▼ -2.6% |
| 2023 | 1.04x | ₩10.22 Billion | ₩9.82 Billion | ▼ -70.1% |
| 2022 | 3.49x | ₩9.16 Billion | ₩2.63 Billion | ▲ +198.0% |
| 2021 | 1.17x | ₩11.14 Billion | ₩9.52 Billion | ▲ +36.6% |
| 2019 | 0.86x | ₩2.86 Billion | ₩3.35 Billion | ▼ -87.3% |
| 2016 | 6.72x | ₩5.03 Billion | ₩748.74 Million | ▲ +32.1% |
| 2015 | 5.09x | ₩4.93 Billion | ₩969.74 Million | ▲ +197.5% |
| 2013 | 1.71x | ₩3.71 Billion | ₩2.17 Billion | ▲ +4.0% |
| 2012 | 1.64x | ₩3.83 Billion | ₩2.33 Billion | ▼ -52.8% |
| 2011 | 3.48x | ₩4.10 Billion | ₩1.18 Billion | — |